SEC Filing Summary: Pacific Biosciences of California, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by Pacific Biosciences of California, Inc. on March 7, 2013, covering events occurring on March 5, 2013. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 5.02 regarding director departures and does not contain financial statements.
Material Changes
The primary material change reported is the alteration of the Board of Directors composition:
- Susan Siegel: Resigned as a Class I director, effective on or before the 2013 Annual Meeting of Stockholders.
- David Singer: Declined to stand for re-election as a Class III director but will continue serving until the 2013 Annual Meeting of Stockholders.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific director changes noted above.
Key Facts for Investor Verification
- Confirm the exact date of the 2013 Annual Meeting of Stockholders to determine the effective end of service for Susan Siegel and David Singer.
- Verify if the Company has announced nominees to replace the departing directors.
- Review subsequent filings to determine if these departures were accompanied by any undisclosed disagreements or other material events.